Directory
>
Kevin Oliver
Kevin Oliver
Group Leader - Novel Target Discovery and Validation Group | Acadia Pharmaceuticals Inc.
Texas, Fort Worth, United States
Kevin Oliver
Summary
Kevin Oliver is a seasoned executive with extensive experience in the pharmaceutical industry, currently serving as the Chief Business Officer at Acadia Pharmaceuticals. With a strong background in corporate strategy and business development, he has successfully led teams in various high-impact roles at renowned organizations such as Merck and Alcon. His expertise spans a wide range of areas including licensing, acquisitions, and innovative therapeutic development, particularly in neurology and oncology. Kevin's leadership style emphasizes collaboration and strategic partnerships, making him a sought-after figure in the industry. He holds a PhD in Neuroscience from the University of Cambridge and a BSc in Immunology & Molecular Biology from King's College London. Kevin's passion for advancing healthcare solutions is evident in his commitment to bringing transformative therapies to market.
Kevin Oliver
Work Experience
Chief Business Officer at
Acadia Pharmaceuticals Inc.
July 2023 - Present
Kevin Oliver
Education
King's College London, U. of London, Bachelor of Science (B.Sc.), Immunology & Molecular Biology
January 1987 - January 1990
University of Cambridge, Doctor of Philosophy (PhD), Neuroscience
January 1992 - January 1995
Frequently Asked Questions about Kevin Oliver
What is Kevin Oliver email address?
Kevin Oliver's primary email address is ************@merck.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Kevin Oliver work for?
Kevin Oliver is a Group Leader - Novel Target Discovery and Validation Group at Acadia Pharmaceuticals Inc..
Where Kevin Oliver graduated from?
Kevin Oliver holds a degree in null from King's College London, U. of London.
How can I directly contact Kevin Oliver?
To contact Kevin Oliver directly, you can use the email address ************@merck.com. Complete contact information is available upon registration with Muraena.
Who is Kevin Oliver?
Kevin Oliver is a seasoned executive with extensive experience in the pharmaceutical industry, currently serving as the Chief Business Officer at Acadia Pharmaceuticals. With a strong background in corporate strategy and business development, he has successfully led teams in various high-impact roles at renowned organizations such as Merck and Alcon. His expertise spans a wide range of areas including licensing, acquisitions, and innovative therapeutic development, particularly in neurology and oncology. Kevin's leadership style emphasizes collaboration and strategic partnerships, making him a sought-after figure in the industry. He holds a PhD in Neuroscience from the University of Cambridge and a BSc in Immunology & Molecular Biology from King's College London. Kevin's passion for advancing healthcare solutions is evident in his commitment to bringing transformative therapies to market.
Kevin`s contact details
************@merck.com
************@alcon.com
************@acadia.com
Colleagues
Director
Associate Director, Sales Operations and other Sales and Sales Leadership Roles
Scientist
Commercial Services
Certified Public Accountant
Clinical Research Associate
Analyst (formerly Defined Health)
Sales Representative / Account Management.
Director, QA
Assistant Professor Department of Pediatrics